These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

278 related articles for article (PubMed ID: 10434578)

  • 21. Unexpected improvement in levodopa-induced dyskinesia and on-off phenomena after introduction of memantine for treatment of Parkinson's disease dementia.
    Vidal EI; Fukushima FB; Valle AP; Villas Boas PJ
    J Am Geriatr Soc; 2013 Jan; 61(1):170-2. PubMed ID: 23311565
    [No Abstract]   [Full Text] [Related]  

  • 22. Addiction as aberrant learning-evidence from Parkinson's disease.
    Dagher A
    Addiction; 2012 Feb; 107(2):248-50. PubMed ID: 22248132
    [No Abstract]   [Full Text] [Related]  

  • 23. Parkinson's disease. Second of two parts.
    Lang AE; Lozano AM
    N Engl J Med; 1998 Oct; 339(16):1130-43. PubMed ID: 9770561
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Does levodopa therapy delay death in Parkinson's disease?
    Uitti RJ; Ahlskog JE; Maraganore DM
    Mov Disord; 1996 May; 11(3):343-4. PubMed ID: 8723162
    [No Abstract]   [Full Text] [Related]  

  • 25. Levodopa therapy for Parkinson's disease: challenges and future prospects.
    Olanow CW; Lees A; Obeso J
    Mov Disord; 2008; 23 Suppl 3():S495-6. PubMed ID: 18781670
    [No Abstract]   [Full Text] [Related]  

  • 26. Current controversies: levodopa in the treatment of Parkinson's disease.
    Sharma JC; Vassallo M; Ross IN
    Mov Disord; 2005 May; 20(5):642-3; author reply 643-4. PubMed ID: 15732129
    [No Abstract]   [Full Text] [Related]  

  • 27. [Levodopa: from a discovery to new elaborations].
    Katunina EA; Avakian GN; Titova NV; Bezdol'nyĭ IuN; Malykhina EA
    Zh Nevrol Psikhiatr Im S S Korsakova; 2010; 110(4):97-103. PubMed ID: 20597201
    [No Abstract]   [Full Text] [Related]  

  • 28. Modern treatment of Parkinson's disease.
    Pearce JM
    Br J Hosp Med; 1987 Jan; 37(1):59, 61, 64-6. PubMed ID: 3545340
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Excitability of the lower-limb area of the motor cortex in Parkinson's disease.
    Vacherot F; Attarian S; Eusebio A; Azulay JP
    Neurophysiol Clin; 2010 Aug; 40(4):201-8. PubMed ID: 20674816
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pathological gambling in two patients on dopamine replacement therapy for Parkinson's disease.
    Avanzi M; Uber E; Bonfà F
    Neurol Sci; 2004 Jun; 25(2):98-101. PubMed ID: 15221629
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Suicide following duodenal levodopa infusion for Parkinson's disease.
    Santos-García D; Macías M; Llaneza M; Aneiros A
    Mov Disord; 2009 Oct; 24(13):2029-30. PubMed ID: 19645071
    [No Abstract]   [Full Text] [Related]  

  • 32. Dopaminergic modulation of cognitive function-implications for L-DOPA treatment in Parkinson's disease.
    Cools R
    Neurosci Biobehav Rev; 2006; 30(1):1-23. PubMed ID: 15935475
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Sleep complaints and their relation with drug treatment in patients suffering from Parkinson's disease.
    Gómez-Esteban JC; Zarranz JJ; Lezcano E; Velasco F; Ciordia R; Rouco I; Losada J; Bilbao I
    Mov Disord; 2006 Jul; 21(7):983-8. PubMed ID: 16602112
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Levodopa in the treatment of Parkinson's disease: current controversies.
    Gerlach M; Reichmann H; Riederer P
    Mov Disord; 2005 May; 20(5):643; author reply 643-4. PubMed ID: 15732130
    [No Abstract]   [Full Text] [Related]  

  • 35. [Early treatment of Parkinson's disease with levodopa].
    Odekerken VJ; Post B; Verschuur CV; de Bie RM
    Ned Tijdschr Geneeskd; 2009; 153():A286. PubMed ID: 19785822
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Parkinson's diseases: power of search].
    Agid Y
    Rev Neurol (Paris); 2010 Oct; 166(10):755. PubMed ID: 20801469
    [No Abstract]   [Full Text] [Related]  

  • 37. Medical hazards of the internet: gambling in Parkinson's disease.
    Larner AJ
    Mov Disord; 2006 Oct; 21(10):1789. PubMed ID: 16941457
    [No Abstract]   [Full Text] [Related]  

  • 38. Early therapy for Parkinson's disease.
    Olanow CW
    Eur Neurol; 1992; 32 Suppl 1():30-5. PubMed ID: 1358615
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Parkinson disease. Directed use of modern therapy].
    Möller JC; Wächter T; Oertel WH
    MMW Fortschr Med; 2001 May; 143 Suppl 2():45-50. PubMed ID: 11434257
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Presynaptic mechanisms of motor fluctuations in Parkinson's disease: a probabilistic model.
    de la Fuente-Fernández R; Schulzer M; Mak E; Calne DB; Stoessl AJ
    Brain; 2004 Apr; 127(Pt 4):888-99. PubMed ID: 14960500
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.